Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1929 1
1937 1
1938 1
1939 1
1942 2
1946 1
1948 1
1951 2
1953 1
1954 2
1957 2
1958 2
1960 1
1961 2
1962 3
1963 8
1965 1
1966 1
1969 1
1973 1
1977 3
1978 1
1981 1
1982 3
1984 1
1985 2
1988 3
1989 1
1990 4
1991 7
1992 10
1993 12
1994 11
1995 12
1996 10
1997 16
1998 8
1999 9
2000 8
2001 9
2002 9
2003 16
2004 26
2005 22
2006 44
2007 44
2008 66
2009 111
2010 17
2011 19
2012 18
2013 20
2014 20
2015 16
2016 21
2017 14
2018 16
2019 9
2020 4
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 19696226

636 results
Results by year
Filters applied: . Clear all
Page 1
Renal volume, renin-angiotensin-aldosterone system, hypertension, and left ventricular hypertrophy in patients with autosomal dominant polycystic kidney disease.
Schrier RW. Schrier RW. J Am Soc Nephrol. 2009 Sep;20(9):1888-93. doi: 10.1681/ASN.2008080882. Epub 2009 Aug 20. J Am Soc Nephrol. 2009. PMID: 19696226 Free article. Review.
Contribution of renal innervation to hypertension in rat autosomal dominant polycystic kidney disease.
Gattone VH 2nd, Siqueira TM Jr, Powell CR, Trambaugh CM, Lingeman JE, Shalhav AL. Gattone VH 2nd, et al. Exp Biol Med (Maywood). 2008 Aug;233(8):952-7. doi: 10.3181/0802-RM-54. Epub 2008 May 14. Exp Biol Med (Maywood). 2008. PMID: 18480417
Optimal care of autosomal dominant polycystic kidney disease patients.
Schrier RW. Schrier RW. Nephrology (Carlton). 2006 Apr;11(2):124-30. doi: 10.1111/j.1440-1797.2006.00535.x. Nephrology (Carlton). 2006. PMID: 16669974 Review.
Interpretation of renal volume in autosomal dominant polycystic kidney disease and relevant clinical implications.
Masoumi A, Elhassan E, Schrier RW. Masoumi A, et al. Iran J Kidney Dis. 2011 Jan;5(1):1-8. Iran J Kidney Dis. 2011. PMID: 21189426 Free article. Review.
Hypertension and left ventricular hypertrophy in autosomal dominant polycystic kidney disease.
Ecder T, Schrier RW. Ecder T, et al. Expert Rev Cardiovasc Ther. 2004 May;2(3):369-74. doi: 10.1586/14779072.2.3.369. Expert Rev Cardiovasc Ther. 2004. PMID: 15151483 Review.
Autosomal dominant polycystic kidney disease: role of the renin-angiotensin system in raised blood pressure in progression of renal and cardiovascular disease.
Lawson CR, Doulton TW, MacGregor GA. Lawson CR, et al. J Renin Angiotensin Aldosterone Syst. 2006 Sep;7(3):139-45. doi: 10.3317/jraas.2006.023. J Renin Angiotensin Aldosterone Syst. 2006. PMID: 17094050 Free article. Review.
Left ventricular hypertrophy in autosomal dominant polycystic kidney disease.
Chapman AB, Johnson AM, Rainguet S, Hossack K, Gabow P, Schrier RW. Chapman AB, et al. J Am Soc Nephrol. 1997 Aug;8(8):1292-7. J Am Soc Nephrol. 1997. PMID: 9259356 Free article.
Borderline hypertensive autosomal dominant polycystic kidney disease patients have enhanced production of renal dopamine. Normalization of renal haemodynamics by DOPA infusion.
Barendregt JN, Florijn KW, Muizert Y, Chang PC. Barendregt JN, et al. Nephrol Dial Transplant. 1995;10(8):1332-41. Nephrol Dial Transplant. 1995. PMID: 8538923
[Blood pressure, functional and morphological study of kidneys in children with autosomal dominant polycystic kidney disease].
Seeman T, Vondrichová H, Strízová J, Sikut M, Janda J, Schärer K. Seeman T, et al. Cas Lek Cesk. 1999 Mar 15;138(6):178-84. Cas Lek Cesk. 1999. PMID: 10510532 Czech.
Hypertension in autosomal dominant polycystic kidney disease.
Chapman AB, Stepniakowski K, Rahbari-Oskoui F. Chapman AB, et al. Adv Chronic Kidney Dis. 2010 Mar;17(2):153-63. doi: 10.1053/j.ackd.2010.01.001. Adv Chronic Kidney Dis. 2010. PMID: 20219618 Free PMC article. Review.
636 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback